Clinical Trials in New York

Showing 12481-12500 of 22,668 trials

Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

NCT04027023

This phase IV study is a prospective open-label multi-center study to investigate the effect of a temporary individualized poly-pharmaceutical De-escalation treatment with the target to regenerate ß-cell function over 12 weeks on the disease stage and glycemic control in patients with type 2 diabetes. This is an uncontrolled pilot study to collect data for later confirmatory trials.

Diabetes Mellitus, Type 2

Sciema UG9 participantsStarted Oct 2019

New York, New York, United States • Mainz, Rhineland-Palatinate, Germany

COMPLETEDPhase 4< 1 mile

Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

NCT04030091

This study is an open label, prospective, randomised comparative, single center study. In the present study, the impact of a 12-week pulsatile insulin infusion therapy (PIT) with Humulin R 100 from

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Sciema UG24 participantsStarted Sep 2019

New York, New York, United States • Mainz, Rhineland-Palatinate, Germany

Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

Find Trials by Condition in New York

Implementation of Brief Dynamic Interpersonal Therapy at the VA

The Efficacy of the Nanit-Insights App in Improving Infant Sleep

Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)

Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis

GLORIA-AF Registry Program - Second and Third Phases

Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease

Clinical Study to Compare 3 Multi-Layered Foam Dressings for the Management of Chronic Wounds

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone

Evaluating Anodal tDCS Preceding Aphasia Therapy

Effectiveness of Physical Therapy Interventions for Low Back Pain Targeting the Low Back Only or Low Back Plus Hips

Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes

Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness

The Diet Gout Trial

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children